The heat shock protein Hsp9O is known as an essential component of several signal transduction pathways and has now been identified as an essential host factor for hepatitis B virus replication. Hsp9O interacts with the viral reverse transcriptase to facilitate the formation of a ribonucleoprotein (RNP) complex between the polymerase and an RNA ligand. This RNP complex is required early in replication for viral assembly and initiation of DNA synthesis through a protein-priming mechanism. These results thus invoke a role for the Hsp9O pathway in the formation of an RNP.
Hepatitis B viruses (hepadnaviruses) are a group of small DNA viruses that replicate through a reverse transcription pathway. Reverse transcription in these viruses is initiated by a protein-priming mechanism as depicted in Fig. 1 . The virally encoded reverse transcriptase binds to a short RNA sequence located at the 5' end of the viral pregenomic RNA (the template for reverse transcription), termed £, and initiates DNA synthesis de novo by using a tyrosine residue within the polymerase polypeptide as the primer (the protein-priming reaction) (2, 3) . In addition, binding of the reverse transcriptase to e triggers nucleocapsid assembly, thus ensuring packaging of the RNA pregenome and the polymerase into nucleocapsids where reverse transcription takes place (4, 5) . Therefore, the formation of a specific ribonucleoprotein (RNP) complex between the reverse transcriptase and s is critical for viral assembly and DNA synthesis (1, 4, (6) (7) (8) (9) (10) .
Since the RNP complex between the reverse transcriptase and £ RNA is transient (1, 7) , its formation most likely depends on a particular conformation of the polymerase that is competent for binding to s. An important question is how the polymerase is stabilized in such a conformation that allows for formation of the RNP complex. To address this problem, we have exploited a recently developed cell-free system that permits expression of an enzymatically active reverse transcriptase of an avian hepadnavirus, the duck hepatitis B virus (DHBV), in a rabbit reticulocyte lysate (RL) (2, 3, 7) . With the help of this system, we have identified a molecular chaperone, the heat shock protein Hsp9O, as an essential host factor required for the polymerase activity in vitro and in vivo. Hsp90 binds to the polymerase and facilitates the interaction between the polymerase and the £ RNA and thus plays an essential role in initiation of viral DNA synthesis and RNA packaging.
MATERIALS AND METHODS
Plasmids. Plasmids pHP and pHTP for expression of the DHBV polymerase in vitro have been described (3) . pT3.1118 (11) , used for in vitro expression of the glucocorticoid receptor (GR), was provided by K. Yamamoto (University of California, San Francisco). pCMV-DHBV directs expression of the DHBV pregenome from the cytomegalovirus immediate early promoter (12, 13 DHBV by replacing the cytomegalovirus promoter with the tetracycline-responsive promoter from pUHD10-3 (14) . pUHD15-1, expressing the tetracycline repressor-VP16 activator fusion protein, was provided by H. Bujard (University of Heidelberg, Heidelberg) (14) .
Antibodies and Reagents. The 3G3 monoclonal antibody (mAb) against Hsp9O was purchased from Affinity Bioreagents (Neshanic Station, NJ). Two additional Hsp9O mAbs, SPA 845 and SPA 835, were from Stressgen. The control mouse IgM (TEPC-183) and goat anti-mouse IgM (IgG fraction) were from Sigma. The rabbit anti-DHBV core antiserum was provided by W. Mason (Fox Chase Cancer Center, Philadelphia) (15) . The antibiotic geldanamycin (GA) was obtained from the Drug Synthesis and Chemistry Branch, National Cancer Institute.
Protein-Priming Reaction. Plasmid DNAs were first linearized with the restriction endonuclease Afl II and then transcribed with an in vitro transcription kit (MEGAscript, Ambion, Austin, TX (17) was cotransfected with pTet-DHBV and pUHD15-1 by the calcium phosphate procedure (1) . Tetracycline (1 ,ug/ml) was added to the culture medium to repress transcription during the transfection period. After removal of tetracycline, transfected cells were treated with various concentrations of GA as indicated. Cells were harvested three days after transfection.
Analysis of Viral RNA and DNA. Replicative viral DNA intermediates were purified from cytoplasmic core particles and examined by Southern blot analysis as described (18, 19) . Total cellular RNA was extracted by a one-step guanidinium method (20) . To eliminate possible plasmid DNA contamination, resuspended RNA was digested with RNase-free DNase I (200 units/ml), phenol/chloroform-extracted, and ethanolprecipitated. Core (encapsidated) RNAs were extracted from cytoplasmic core particles obtained by polyethylene glycol precipitation (19) . Nonencapsidated nucleic acids were digested with micrococcal nuclease (130 units/ml) and RNasefree DNase I (100 units/ml), in a buffer containing 5 mM MgCl2 and 5 mM CaCl2, both before and after the polyethylene glycol precipitation step (8, 21) . Core particles were then disrupted by proteinase K (600 ,ug/ml)/SDS (0.6%) treatment and core nucleic acids were isolated by phenol/chloroform extraction and ethanol precipitation. Core DNAs were removed by RNase-free DNase I digestion (100 units/ml) and core RNAs were phenol/chloroform-extracted and ethanolprecipitated. The (2, 7) that the DHBV reverse transcriptase expressed in vitro in the RL is active in the proteinpriming reaction and forms a stable RNP complex with e RNA. We subsequently attempted to express the polymerase in another in vitro translation system, the WG. Surprisingly, the protein-priming activity of the polymerase expressed in the WG was at least 50-fold reduced as compared to the RL ( Fig.  2A, lanes 1 and 3) . Furthermore, this reduced activity to prime DNA synthesis directly correlated with the low efficiency by which the polymerase could form an RNP complex with E in the WG, as determined with an RNA binding assay (Fig. 2B,  lanes 1 and 3) . Remarkably, RNA binding and DNA priming activities could be dramatically stimulated by the addition of RL to the polymerase expressed in the WG after the translation reaction was stopped (Fig. 2, lanes 2) . These results suggested that one or several factor(s) present in the RL, but deficient in the WG, are required for the interaction between the polymerase and E RNA. Initial fractionation experiments with the RL showed that these factors were cytosolic and at least one of the components had a molecular mass of more than 100 kDa (data not shown). However, the polymerase stimulating activity in the RL decreased rapidly upon further purification and preliminary efforts to biochemically purify these putative factors were, so far, not successful.
DHBV (23, 26, 27) . Hsp9O mAbs Block RNP Formation Between the Polymerase and E RNA. The significance of the association between the polymerase and Hsp90 for the protein-priming and E binding reactions became apparent when the polymerase activities were assayed in the presence of the anti-Hsp90 antibodies. Addition of the mAb 3G3 to the protein-priming reaction after the polymerase was allowed to form a complex with e reduced the DNA priming activity only 2-fold ( Fig. 4A  and D) . In contrast, addition of the mAb to the reaction mixture prior to the incubation of the polymerase with E inhibited the protein-priming activity at least 50-fold (Fig. 4 B  and D) . Two additional anti-Hsp9O mAbs (SPA-835 and SPA-845) showed effects similar to those of mAb 3G3 (data not shown). As expected from these results, the Hsp90 antibodies also abrogated the ability of the RL to activate the priming activity of the polymerase translated in the WG (data not shown). These observations indicated that Hsp9O antibodies interfered with the ability of the polymerase to bind to E RNA. This view was confirmed when we directly demonstrated, with the help of the RNA binding assay, that mAb 3G3 efficiently inhibited the binding of E RNA to the reverse transcriptase (Fig. 4 C and D function of several steroid receptors and the tyrosine kinase v-src, all of which are known to depend on Hsp9O for activity (28, 29) . A direct effect of GA is to block the interaction between Hsp9O and p23, a ubiquitously expressed phosphoprotein required for Hsp90 function (28, 30, 31) . First, we demonstrated that GA could inhibit the in vitro proteinpriming activity of the polymerase but only when it was incubated with the polymerase prior to the addition of E RNA ( Fig. 5 B and C) . In reactions where the polymerase was already in a complex with 8, protein-priming activity was not affected by the drug (Fig. 5 A and C) . This result showed that GA, like the anti-Hsp90 antibodies, did not inhibit the DNA polymerization reaction per se but rather diminished RNP formation between the polymerase and 8. concentrations of GA. Three days after transfection, replicative viral DNA intermediates were analyzed by Southern blot analysis. Fig. 6A and C shows an inverse relationship between the relative amount of replicative DHBV DNA and the concentration of GA added to the culture medium. At the maximal drug concentration used, inhibition of viral DNA synthesis was approximately 10-fold. To test whether GA inhibited viral RNA packaging, as predicted by our model, we measured the levels of encapsidated pregenomic RNA in relation to the total (free and packaged) amounts of pregenome in transfected cells. As a control for this experiment, we used a DHBV variant, CA13, that is defective for RNA packaging and DNA synthesis (C.S., unpublished results). The ratio of packaged versus total pregenomic RNA extracted from cells transfected with CA13 was less than 1:10, as compared to that observed with wild-type DHBV, which was approximately 1:1. As predicted, addition of GA to the culture medium reduced the ratio of packaged RNA to total pregenomic RNA in a concentration-dependent manner (Fig. 6 B  and C) . At the highest concentration examined, GA decreased the efficiency of viral RNA packaging approximately 10-fold. Under our selected conditions, the drug showed no significant effect on the production of viral core protein or the expression of a transfected chloramphenicol acetyltransferase reporter gene. These results indicated that the observed antiviral effect of GA was due to its specific inhibition on the interaction between the reverse transcriptase and e, thus confirming the observation made with in vitro-synthesized polymerase. An unexpected observation was that much lower concentrations of GA were effective in cell cultures as compared to the selected conditions in vitro. It is conceivable that GA accumulated in cells to concentrations comparable to those present in the RL. Alternatively, the observed discrepancy could reflect a difference in the availability of Hsp9O in cells versus in the RL. Interestingly, similar observations were reported with v-src, the activity of which also depends on Hsp9O (29) .
Like the steroid receptors, the reverse transcriptase of hepatitis B viruses acts as a target for and forms a complex with a specific ligand, the e RNA, to carry out the priming step of reverse transcription and to initiate nucleocapsid assembly. Furthermore, this interaction must be transient in nature since the RNA has to be displaced from the polymerase active site by sequences from the 3' end of the pregenomic RNA, which acts as the template for the subsequent elongation step in viral DNA synthesis (Fig. 1) . A unique conformation of the polymerase is likely to be required for the initial priming reaction-a highly specialized function-that is different from that needed for the subsequent elongation reaction. Based on the results presented, we propose that Hsp9O is required to maintain the polymerase in such a "priming" conformation that permits the interaction with 8. Thus in the absence of RNA, the polymerase is in a complex that resembles the aporeceptor complex proposed for the steroid receptors, which includes an Hsp9O dimer, p23, and additional accessory proteins. Indeed, we have obtained preliminary results that indicate that p23 is associated with the polymerase and may also play a role in facilitating the interaction between the polymerase and 8 Biochemistry: Hu and Seeger factor in the Hsp90 folding pathway which is deficient in the WG (27) . In addition, recent genetic and biochemical evidence invokes a role for Hsp70 (DnaK) and its partner DnaJ as participants in the Hsp90 folding pathway in an ATPdependent process (24, 25, 32, 33) . In accord with this model, we observed that mAb against Hsp7O or removal of ATP also diminished RNP formation between the polymerase and e. A difference between the observations described here and previous results (24, 25) obtained with the steroid receptors is that the polymerase does not appear to dissociate from the Hsp90 complex after the binding to its ligand. Exit from the Hsp90 folding pathway may be induced by the viral core proteins during the nucleocapsid assembly process that, under natural conditions, ensures RNP formation between the polymerase and s.
In summary, our results have identified Hsp9O as an essential host factor required for reverse transcription of a viral genome and revealed a role of this molecular chaperone in the formation of an RNP complex. The system described here may provide a tool to investigate the function of Hsp90, which is essential for cell growth but whose exact role still remains elusive.
